TRBC2 and T-cell non-Hodgkin lymphoma: Therefore, this and the reciprocal TRBC2-specific approaches may benefit patients with peripheral T-cell lymphoma as well as a small fraction of T-ALL patients, without inducing complete T-cell ablation.